The choice of models and adherence to regulatory requirements must be carefully strategized for in-vivo studies that leverage safety pharmacology expertise. AmplifyBio utilizes over 30 years of experience leading preclinical research, creating toxicological solutions, developing modern pharmacokinetics, and assisting with many other extensive studies. We work with our partners, providing experienced study designs for chosen models (human and animal trials) with physiological expertise to interpret and implement data in real-time. Our skilled team can adjust as needed and will conduct testing that meets regulatory requirements, including ICH safety pharmacology S7A and S7 standards.
AmplifyBio coordinates and curates customized safety pharmacology studies in a wide variety of animal models. The most common testing applications are cardiovascular, central nervous system (CNS), pulmonary, and renal therapies.
Our assessment capabilities include:
At AmplifyBio, we use more than safety pharmacology expertise and best practices to assist with testing. We know that picking the best animal model, designing the right study, and being prepared to analyze all data with pharmacology and physiological expertise positions us to expect the unexpected and adjust at a moment’s notice.
Our global partnerships, including our research collaboration with Battelle, enable new levels of innovation:
With the expertise to design the right study for every model and flexibility for data-driven implementation, Amplifybio is your partner to trust for in-vivo safety pharmacology assistance. Talk with us and discover how we can support your preclinical studies and compliance requirements.